1. Anti‐glycoprotein VI mediated immune thrombocytopenia: An under‐recognized and significant entity?. Issue 2 (24th August 2017) Authors: Rabbolini, David J.; Gardiner, Elizabeth E.; Morel‐Kopp, Marie‐Christine; Dunkley, Scott; Jahangiri, Anila; Lee, Christine S‐M.; Stevenson, William S.; Ward, Christopher M. Journal: Research and practice in thrombosis and haemostasis Issue: Volume 1:Issue 2(2017) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia. (17th November 2018) Authors: Rabbolini, David J.; Chun, Yenna; Latimer, Maya; Kunishima, Shinji; Fixter, Kathleen; Valecha, Bhavia; Tan, Peter; Chew, Lee Ping; Kile, Benjamin T.; Burt, Rachel; Radhakrishnan, Kottayam; Bird, Robert; Ockelford, Paul; Gabrielli, Sara; Chen, Qiang; Stevenson, William S.; Ward, Christopher M.; Mo... Journal: Platelets Issue: Volume 29:Number 8(2018) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Fatty acid synthase and adenosine monophosphate-activated protein kinase regulate cell survival and drug sensitivity in diffuse large B-cell lymphoma. Issue 8 (2nd July 2020) Authors: Gifford, Grace K.; Gifford, Andrew J.; Chen, Qian; Shen, Yandong; Gabrielli, Sara; Gill, Anthony J.; Stevenson, William S.; Best, Oliver Giles Journal: Leukemia & lymphoma Issue: Volume 61:Issue 8(2020) Page Start: 1810 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. GFI1B variants associated with thrombocytopenia. (4th July 2017) Authors: Rabbolini, David J.; Morel-Kopp, Marie-Christine; Ward, Christopher M.; Stevenson, William S. Journal: Platelets Issue: Volume 28:Number 5(2017) Page Start: 525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment‐free and overall survival in Chronic Lymphocytic Leukaemia. (21st February 2018) Authors: Crassini, Kyle R.; Zhang, Eva; Balendran, Shalini; Freeman, Jane A.; Best, O. Giles; Forsyth, Cecily J.; Mackinlay, Naomi J.; Han, Ping; Stevenson, William S.; Mulligan, Stephen P. Journal: British journal of haematology Issue: Volume 181:Number 1(2018) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells. Issue 12 (2nd December 2018) Authors: Crassini, Kyle; Pyke, Tahni; Shen, Yandong; Stevenson, William S.; Christopherson, Richard I.; Mulligan, Stephen P.; Best, Oliver Giles Journal: Leukemia & lymphoma Issue: Volume 59:Issue 12(2018) Page Start: 2917 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT‐737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment. (16th May 2018) Authors: Crassini, Kyle; Shen, Yandong; Stevenson, William S.; Christopherson, Richard; Ward, Chris; Mulligan, Stephen P.; Best, O. Giles Journal: British journal of haematology Issue: Volume 182:Number 3(2018) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Molecular pathogenesis of chronic lymphocytic leukaemia. (31st July 2019) Authors: Crassini, Kyle; Stevenson, William S.; Mulligan, Stephen P.; Best, O. Giles Journal: British journal of haematology Issue: Volume 186:Number 5(2019) Page Start: 668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The clinical heterogeneity of RUNX1 associated familial platelet disorder with predisposition to myeloid malignancy – A case series and review of the literature. Issue 1 (13th December 2019) Authors: Tang, Catherine; Rabbolini, David J.; Morel‐Kopp, Marie‐Christine; Connor, David E.; Crispin, Philip; Ward, Christopher M.; Stevenson, William S. Journal: Research and practice in thrombosis and haemostasis Issue: Volume 4:Issue 1(2020) Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The MEK1/2 inhibitor, MEKi-1, induces cell death in chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine. Issue 12 (2nd December 2015) Authors: Crassini, Kyle; Stevenson, William S.; Mulligan, Stephen P.; Best, O. Giles Journal: Leukemia & lymphoma Issue: Volume 56:Issue 12(2015:Dec.) Page Start: 3407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗